Drugs for inflammatory conditions drove nearly half of spending in commercial plans last year, a new report shows. Express Scripts released its annual Drug Trend Report, which analyzes costs and ...
The Biden administration has walked back a last-minute bid by its predecessor to give Part D plans the ability to restrict access to certain classes of drugs such as antidepressants. The Centers for ...
GLP-1 drugs are predicted to become the top-selling pharmaceutical class ever, with projected US sales of $150 billion by 2030. I have written multiple articles on GLP-1 drugs, highlighting their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback